Selected research
Industry Research
Nicotinamide Phosphoribosyltransferase Industry Research Report 2026
Market perspective
The global Nicotinamide Phosphoribosyltransferase market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Nicotinamide Phosphoribosyltransferase is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Nicotinamide Phosphoribosyltransferase is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Nicotinamide Phosphoribosyltransferase is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Nicotinamide Phosphoribosyltransferase include OncoTartis, Inc., Karyopharm Therapeutics, Inc., Genentech, Inc., FORMA Therapeutics, Inc., Calico LLC, Aurigene Discovery Technologies Limited and Angelini Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Nicotinamide Phosphoribosyltransferase market in terms of revenue (US$ million) and, where applicable, sales volume (W Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Nicotinamide Phosphoribosyltransferase Market by Company
OncoTartis, Inc.
Karyopharm Therapeutics, Inc.
Genentech, Inc.
FORMA Therapeutics, Inc.
Calico LLC
Aurigene Discovery Technologies Limited
Angelini Group
Nicotinamide Phosphoribosyltransferase Segment by Type
Lipids
Small Molecule Compounds
Hormone
Others
Nicotinamide Phosphoribosyltransferase Segment by Application
Breast Cancer
Parkinson's Disease
Acute Lung Injury
Others
Nicotinamide Phosphoribosyltransferase Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nicotinamide Phosphoribosyltransferase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nicotinamide Phosphoribosyltransferase and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nicotinamide Phosphoribosyltransferase.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Nicotinamide Phosphoribosyltransferase manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Nicotinamide Phosphoribosyltransferase by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Nicotinamide Phosphoribosyltransferase in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Lipids
- Small Molecule Compounds
- Hormone
- Others
Applications
- Breast Cancer
- Parkinson's Disease
- Acute Lung Injury
- Others
Companies covered
- OncoTartis, Inc.
- Karyopharm Therapeutics, Inc.
- Genentech, Inc.
- FORMA Therapeutics, Inc.
- Calico LLC
- Aurigene Discovery Technologies Limited
- Angelini Group
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Nicotinamide Phosphoribosyltransferase Market Size (2021-2032)
- 2.2.2 Global Nicotinamide Phosphoribosyltransferase Sales (2021-2032)
- 2.2.3 Global Nicotinamide Phosphoribosyltransferase Market Average Price (2021-2032)
- 2.3 Nicotinamide Phosphoribosyltransferase by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Lipids
- 2.3.3 Small Molecule Compounds
- 2.3.4 Hormone
- 2.3.5 Others
- 2.4 Nicotinamide Phosphoribosyltransferase by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Breast Cancer
- 2.4.3 Parkinson's Disease
- 2.4.4 Acute Lung Injury
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Nicotinamide Phosphoribosyltransferase Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Nicotinamide Phosphoribosyltransferase Sales (W Tons) of Manufacturers (2021-2026)
- 3.3 Global Nicotinamide Phosphoribosyltransferase Revenue of Manufacturers (2021-2026)
- 3.4 Global Nicotinamide Phosphoribosyltransferase Average Price by Manufacturers (2021-2026)
- 3.5 Global Nicotinamide Phosphoribosyltransferase Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Nicotinamide Phosphoribosyltransferase, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Nicotinamide Phosphoribosyltransferase, Product Type & Application
- 3.8 Global Manufacturers of Nicotinamide Phosphoribosyltransferase, Established Date
- 3.9 Global Nicotinamide Phosphoribosyltransferase Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 OncoTartis, Inc.
- 4.1.1 OncoTartis, Inc. Company Information
- 4.1.2 OncoTartis, Inc. Business Overview
- 4.1.3 OncoTartis, Inc. Nicotinamide Phosphoribosyltransferase Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 OncoTartis, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio
- 4.1.5 OncoTartis, Inc. Recent Developments
- 4.2 Karyopharm Therapeutics, Inc.
- 4.2.1 Karyopharm Therapeutics, Inc. Company Information
- 4.2.2 Karyopharm Therapeutics, Inc. Business Overview
- 4.2.3 Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio
- 4.2.5 Karyopharm Therapeutics, Inc. Recent Developments
- 4.3 Genentech, Inc.
- 4.3.1 Genentech, Inc. Company Information
- 4.3.2 Genentech, Inc. Business Overview
- 4.3.3 Genentech, Inc. Nicotinamide Phosphoribosyltransferase Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Genentech, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio
- 4.3.5 Genentech, Inc. Recent Developments
- 4.4 FORMA Therapeutics, Inc.
- 4.4.1 FORMA Therapeutics, Inc. Company Information
- 4.4.2 FORMA Therapeutics, Inc. Business Overview
- 4.4.3 FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio
- 4.4.5 FORMA Therapeutics, Inc. Recent Developments
- 4.5 Calico LLC
- 4.5.1 Calico LLC Company Information
- 4.5.2 Calico LLC Business Overview
- 4.5.3 Calico LLC Nicotinamide Phosphoribosyltransferase Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Calico LLC Nicotinamide Phosphoribosyltransferase Product Portfolio
- 4.5.5 Calico LLC Recent Developments
- 4.6 Aurigene Discovery Technologies Limited
- 4.6.1 Aurigene Discovery Technologies Limited Company Information
- 4.6.2 Aurigene Discovery Technologies Limited Business Overview
- 4.6.3 Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Product Portfolio
- 4.6.5 Aurigene Discovery Technologies Limited Recent Developments
- 4.7 Angelini Group
- 4.7.1 Angelini Group Company Information
- 4.7.2 Angelini Group Business Overview
- 4.7.3 Angelini Group Nicotinamide Phosphoribosyltransferase Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Angelini Group Nicotinamide Phosphoribosyltransferase Product Portfolio
- 4.7.5 Angelini Group Recent Developments
5 Global Nicotinamide Phosphoribosyltransferase Market Scenario by Region
- 5.1 Global Nicotinamide Phosphoribosyltransferase Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Nicotinamide Phosphoribosyltransferase Sales by Region: 2021-2032
- 5.2.1 Global Nicotinamide Phosphoribosyltransferase Sales by Region: 2021-2026
- 5.2.2 Global Nicotinamide Phosphoribosyltransferase Sales by Region: 2027-2032
- 5.3 Global Nicotinamide Phosphoribosyltransferase Revenue by Region: 2021-2032
- 5.3.1 Global Nicotinamide Phosphoribosyltransferase Revenue by Region: 2021-2026
- 5.3.2 Global Nicotinamide Phosphoribosyltransferase Revenue by Region: 2027-2032
- 5.4 North America Nicotinamide Phosphoribosyltransferase Market Facts & Figures by Country
- 5.4.1 North America Nicotinamide Phosphoribosyltransferase Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Nicotinamide Phosphoribosyltransferase Sales by Country (2021-2032)
- 5.4.3 North America Nicotinamide Phosphoribosyltransferase Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Nicotinamide Phosphoribosyltransferase Market Facts & Figures by Country
- 5.5.1 Europe Nicotinamide Phosphoribosyltransferase Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Nicotinamide Phosphoribosyltransferase Sales by Country (2021-2032)
- 5.5.3 Europe Nicotinamide Phosphoribosyltransferase Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Nicotinamide Phosphoribosyltransferase Market Facts & Figures by Country
- 5.6.1 Asia Pacific Nicotinamide Phosphoribosyltransferase Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Nicotinamide Phosphoribosyltransferase Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Nicotinamide Phosphoribosyltransferase Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Nicotinamide Phosphoribosyltransferase Market Facts & Figures by Country
- 5.7.1 South America Nicotinamide Phosphoribosyltransferase Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Nicotinamide Phosphoribosyltransferase Sales by Country (2021-2032)
- 5.7.3 South America Nicotinamide Phosphoribosyltransferase Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Nicotinamide Phosphoribosyltransferase Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Nicotinamide Phosphoribosyltransferase Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Nicotinamide Phosphoribosyltransferase Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Nicotinamide Phosphoribosyltransferase Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Nicotinamide Phosphoribosyltransferase Sales by Type (2021-2032)
- 6.1.1 Global Nicotinamide Phosphoribosyltransferase Sales by Type (2021-2032) & (W Tons)
- 6.1.2 Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Type (2021-2032)
- 6.2 Global Nicotinamide Phosphoribosyltransferase Revenue by Type (2021-2032)
- 6.2.1 Global Nicotinamide Phosphoribosyltransferase Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Type (2021-2032)
- 6.3 Global Nicotinamide Phosphoribosyltransferase Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Nicotinamide Phosphoribosyltransferase Sales by Application (2021-2032)
- 7.1.1 Global Nicotinamide Phosphoribosyltransferase Sales by Application (2021-2032) & (W Tons)
- 7.1.2 Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Application (2021-2032)
- 7.2 Global Nicotinamide Phosphoribosyltransferase Revenue by Application (2021-2032)
- 7.2.1 Global Nicotinamide Phosphoribosyltransferase Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Application (2021-2032)
- 7.3 Global Nicotinamide Phosphoribosyltransferase Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Nicotinamide Phosphoribosyltransferase Value Chain Analysis
- 8.1.1 Nicotinamide Phosphoribosyltransferase Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Nicotinamide Phosphoribosyltransferase Production Mode & Process
- 8.2 Nicotinamide Phosphoribosyltransferase Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Nicotinamide Phosphoribosyltransferase Distributors
- 8.2.3 Nicotinamide Phosphoribosyltransferase Customers
9 Global Nicotinamide Phosphoribosyltransferase Analyzing Market Dynamics
- 9.1 Nicotinamide Phosphoribosyltransferase Industry Trends
- 9.2 Nicotinamide Phosphoribosyltransferase Industry Drivers
- 9.3 Nicotinamide Phosphoribosyltransferase Industry Opportunities and Challenges
- 9.4 Nicotinamide Phosphoribosyltransferase Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst